glp 1 controversy GLP-1 Agonists are often very misunderstood., They are typically associated with treating obesity and type 2 diabetes, but the truth is…, Their potential may extend beyond just weight loss., For many, GLP-1 Medications – Community Education
Description
Muscle quality, insulin sensitivity, mitochondrial efficiency, intramuscular fat , may actually improve on GLP-1 therapy
For best results, we recommend 3-6 months of consistent daily use
Can You Stop GLP-1 Treatment After a Month
Methods We administered male rats with intraperitoneal (i.p.) or intracerebroventricular (i.c.v.) GLP-1R agonist (exendin-4) or antagonist (exendin-9-39) followed by in vivo determination of CSF dynamics
Experts say more education and awareness are needed.
But emerging research suggests amylin agonists might become the next big thing.
